TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License

Bulletin Express

Jan 23

TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.

The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1156381147"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156381147\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156381147?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156381147","market":"us","top_or_hot":-1,"title":"TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License","media":"Bulletin Express","content":"<p>TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.</p>\n<p>The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTYK Medicines, Inc (Stock Code: 2410) Granted Drug Manufacturing License\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-23 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.</p>\n<p>The announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02410","symbol_name":"同源康医药-B","start_time":0,"source_url":"","article_id":"1156381147","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156381147","pubTimestamp":1769168676,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02410":"同源康医药-B"},"translate_title":"TYK Medicines，Inc（股份代号：2410）获授药品生产许可证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02410":1},"content_text":"TYK Medicines, Inc (浙江同源康醫藥股份有限公司) (Stock Code: 2410) announced that it has been granted the Drug Manufacturing License by the Drug Administration of Zhejiang Province. According to the announcement, the license carries the number “Zhejiang 20260002” and remains valid until January 22, 2031. The production address and range designate Asymchem Life Science (Tianjin) Co., Ltd. as trustee manufacturer at No. 71, 7th Street, Economic-Technological Development Area, Tianjin.\nThe announcement indicates that securing this license may facilitate the company’s capacity and market expansion, laying a foundation for subsequent commercial production of cancer-treatment products. Caution is noted under Rule 18A.05 of the Listing Rules, reminding shareholders and potential investors that there is no assurance the relevant product will ultimately be successfully developed or marketed.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}